Indications for Maze Procedure
The maze procedure should be considered in patients with symptomatic atrial fibrillation undergoing cardiac surgery for other indications (Class IIa recommendation), and may be performed as a stand-alone minimally invasive procedure in symptomatic patients after catheter ablation failure (Class IIb recommendation). 1
Primary Indications
Concomitant Cardiac Surgery (Strongest Indication)
- Surgical ablation of AF should be considered in patients with symptomatic AF undergoing cardiac surgery (Class IIa, Level A evidence) 1
- This applies particularly to patients undergoing:
- The procedure achieves 75-95% freedom from AF over 15 years when combined with mitral valve surgery 1
Symptomatic AF Refractory to Medical Management
The maze procedure is indicated when patients have failed conservative treatments including: 2, 5
- Antiarrhythmic medications (beta blockers, amiodarone, other agents)
- Electrical cardioversion
- Rate control strategies
Specific Clinical Scenarios
History of systemic embolism is a compelling indication, particularly when combined with other cardiac surgery 2, 3
Contraindications to anticoagulation make the maze procedure particularly valuable, as successful restoration of sinus rhythm may reduce stroke risk 2, 3
Highly symptomatic AF not well managed with other approaches, especially in younger patients who face decades of potential AF-related complications 1, 2
Stand-Alone Maze Procedure (More Limited Role)
Minimally invasive surgical ablation without concomitant cardiac surgery may be performed in symptomatic patients after catheter ablation failure (Class IIb, Level C evidence) 1
This represents a more selective indication because: 2
- Only 5.3% of AF surgical ablations in the Society of Thoracic Surgeons database were stand-alone procedures
- The procedure requires cardiopulmonary bypass when performed as traditional open surgery 1
- Catheter ablation is typically preferred as second-line therapy after medication failure
Asymptomatic AF (Weaker Indication)
Surgical ablation may be performed in asymptomatic AF patients undergoing cardiac surgery if feasible with minimal risk (Class IIb, Level C evidence) 1
This weaker recommendation reflects uncertainty about benefit in asymptomatic patients, though preventing atrial remodeling and thromboembolic events may justify the approach 1
Patient Selection Factors
Favorable Characteristics
Success rates are higher in patients with: 1
- Smaller left atrial size
- Younger age
- Shorter AF duration (paroxysmal > persistent > permanent)
- Absence of hypertension
- No sleep apnea
Unfavorable Characteristics
The following reduce success but are not absolute contraindications: 1
- Large left atrium (>5.3 cm)
- Advanced age
- Long-standing permanent AF
- Uncontrolled hypertension
- Sleep apnea
Expected Outcomes
Efficacy
- Freedom from atrial tachyarrhythmias: 89-93% at 6-12 months 2
- Freedom from AF without antiarrhythmic drugs: 78-79% at 12 months 2
- Long-term success: 75-95% over 15 years 1
- Quality of life improves significantly to general population levels by 12 months 6
Risks
- Mortality <1% for isolated procedure, higher when combined with other cardiac surgeries 1, 2
- Permanent pacemaker requirement: <10% with modern techniques (historically 4-40%) 7, 4, 8
- Other complications include bleeding, atrial dysfunction, and fluid retention 2
Critical Caveats
Anticoagulation decisions must be based on stroke risk profile (CHA₂DS₂-VASc score), not on whether sinus rhythm is maintained, as AF may recur asymptomatically 1
The procedure does not eliminate the need for long-term anticoagulation in high-risk patients, even when sinus rhythm is successfully restored 1
Consider timing carefully in younger patients: allowing AF to persist for years causes electrical and structural remodeling that may make future rhythm control impossible 1